Clustering data with heatmap algorithm for (Study ST000381)

This analysis uses the 'heatmap.2' function of gplots package in the R statistics environment


The rows are scaled to have mean=0 and standard deviation=1

Factors:

F1Cohort:CSMC | Treatment:ICPBS Urine-IC12 | SubCondition:SEVERE
F2Cohort:CSMC | Treatment:ICPBS Urine-IC14 | SubCondition:SEVERE
F3Cohort:CSMC | Treatment:ICPBS Urine-IC19 | SubCondition:SEVERE
F4Cohort:CSMC | Treatment:ICPBS Urine-IC20 | SubCondition:SEVERE
F5Cohort:CSMC | Treatment:ICPBS Urine-IC21 | SubCondition:SEVERE
F6Cohort:CSMC | Treatment:ICPBS Urine-IC22 | SubCondition:SEVERE
F7Cohort:CSMC | Treatment:ICPBS Urine-IC30 | SubCondition:SEVERE
F8Cohort:CSMC | Treatment:ICPBS Urine-IC31 | SubCondition:SEVERE
F9Cohort:CSMC | Treatment:ICPBS Urine-IC32 | SubCondition:SEVERE
F10Cohort:CSMC | Treatment:ICPBS Urine-IC48 | SubCondition:SEVERE
F11Cohort:CSMC | Treatment:ICPBS Urine-IC52 | SubCondition:SEVERE
F12Cohort:CSMC | Treatment:ICPBS Urine-IC53 | SubCondition:SEVERE
F13Cohort:CSMC | Treatment:ICPBS Urine-IC5 | SubCondition:SEVERE
F14Cohort:CSMC | Treatment:ICPBS Urine-IC9 | SubCondition:SEVERE
F15Cohort:CSMC | Treatment:Matched control-C10 | SubCondition:n/a
F16Cohort:CSMC | Treatment:Matched control-C13 | SubCondition:n/a
F17Cohort:CSMC | Treatment:Matched control-C15 | SubCondition:n/a
F18Cohort:CSMC | Treatment:Matched control-C16 | SubCondition:n/a
F19Cohort:CSMC | Treatment:Matched control-C17 | SubCondition:n/a
F20Cohort:CSMC | Treatment:Matched control-C18 | SubCondition:n/a
F21Cohort:CSMC | Treatment:Matched control-C26 | SubCondition:n/a
F22Cohort:CSMC | Treatment:Matched control-C27 | SubCondition:n/a
F23Cohort:CSMC | Treatment:Matched control-C28 | SubCondition:n/a
F24Cohort:CSMC | Treatment:Matched control-C33 | SubCondition:n/a
F25Cohort:CSMC | Treatment:Matched control-C40 | SubCondition:n/a
F26Cohort:CSMC | Treatment:Matched control-C45 | SubCondition:n/a
F27Cohort:CSMC | Treatment:Matched control-C49 | SubCondition:n/a
F28Cohort:CSMC | Treatment:Matched control-C50 | SubCondition:n/a
F29Cohort:CSMC | Treatment:Matched control-C51 | SubCondition:n/a
F30Cohort:INHA | Treatment:ICPBS Urine-IC 10 | SubCondition:SEVERE
F31Cohort:INHA | Treatment:ICPBS Urine-IC 11 | SubCondition:MODEST
F32Cohort:INHA | Treatment:ICPBS Urine-IC 12 | SubCondition:MODEST
F33Cohort:INHA | Treatment:ICPBS Urine-IC 13 | SubCondition:MODEST
F34Cohort:INHA | Treatment:ICPBS Urine-IC 14 | SubCondition:SEVERE
F35Cohort:INHA | Treatment:ICPBS Urine-IC 15 | SubCondition:SEVERE
F36Cohort:INHA | Treatment:ICPBS Urine-IC 16 | SubCondition:SEVERE
F37Cohort:INHA | Treatment:ICPBS Urine-IC 17 | SubCondition:MODEST
F38Cohort:INHA | Treatment:ICPBS Urine-IC 18 | SubCondition:MODEST
F39Cohort:INHA | Treatment:ICPBS Urine-IC 19 | SubCondition:SEVERE
F40Cohort:INHA | Treatment:ICPBS Urine-IC 1 | SubCondition:SEVERE
F41Cohort:INHA | Treatment:ICPBS Urine-IC 20 | SubCondition:SEVERE
F42Cohort:INHA | Treatment:ICPBS Urine-IC 21 | SubCondition:MODEST
F43Cohort:INHA | Treatment:ICPBS Urine-IC 22 | SubCondition:INTERMEDIATE
F44Cohort:INHA | Treatment:ICPBS Urine-IC 24 | SubCondition:MODEST
F45Cohort:INHA | Treatment:ICPBS Urine-IC 25 | SubCondition:MODEST
F46Cohort:INHA | Treatment:ICPBS Urine-IC 26 | SubCondition:MODEST
F47Cohort:INHA | Treatment:ICPBS Urine-IC 27 | SubCondition:INTERMEDIATE
F48Cohort:INHA | Treatment:ICPBS Urine-IC 28 | SubCondition:MODEST
F49Cohort:INHA | Treatment:ICPBS Urine-IC 29 | SubCondition:SEVERE
F50Cohort:INHA | Treatment:ICPBS Urine-IC 2 | SubCondition:SEVERE
F51Cohort:INHA | Treatment:ICPBS Urine-IC 30 | SubCondition:INTERMEDIATE
F52Cohort:INHA | Treatment:ICPBS Urine-IC 31 | SubCondition:SEVERE
F53Cohort:INHA | Treatment:ICPBS Urine-IC 32 | SubCondition:MODEST
F54Cohort:INHA | Treatment:ICPBS Urine-IC 33 | SubCondition:MODEST
F55Cohort:INHA | Treatment:ICPBS Urine-IC 34 | SubCondition:SEVERE
F56Cohort:INHA | Treatment:ICPBS Urine-IC 35 | SubCondition:SEVERE
F57Cohort:INHA | Treatment:ICPBS Urine-IC 36 | SubCondition:SEVERE
F58Cohort:INHA | Treatment:ICPBS Urine-IC 37 | SubCondition:MODEST
F59Cohort:INHA | Treatment:ICPBS Urine-IC 38 | SubCondition:INTERMEDIATE
F60Cohort:INHA | Treatment:ICPBS Urine-IC 39 | SubCondition:SEVERE
F61Cohort:INHA | Treatment:ICPBS Urine-IC 3 | SubCondition:SEVERE
F62Cohort:INHA | Treatment:ICPBS Urine-IC 40 | SubCondition:INTERMEDIATE
F63Cohort:INHA | Treatment:ICPBS Urine-IC 41 | SubCondition:MODEST
F64Cohort:INHA | Treatment:ICPBS Urine-IC 42 | SubCondition:INTERMEDIATE
F65Cohort:INHA | Treatment:ICPBS Urine-IC 43 | SubCondition:INTERMEDIATE
F66Cohort:INHA | Treatment:ICPBS Urine-IC 4 | SubCondition:INTERMEDIATE
F67Cohort:INHA | Treatment:ICPBS Urine-IC 5 | SubCondition:MODEST
F68Cohort:INHA | Treatment:ICPBS Urine-IC 6 | SubCondition:SEVERE
F69Cohort:INHA | Treatment:ICPBS Urine-IC 7 | SubCondition:MODEST
F70Cohort:INHA | Treatment:ICPBS Urine-IC 8 | SubCondition:INTERMEDIATE
F71Cohort:INHA | Treatment:ICPBS Urine-IC 9 | SubCondition:MODEST
F72Cohort:INHA | Treatment:Matched control-C 10 | SubCondition:n/a
F73Cohort:INHA | Treatment:Matched control-C 11 | SubCondition:n/a
F74Cohort:INHA | Treatment:Matched control-C 12 | SubCondition:n/a
F75Cohort:INHA | Treatment:Matched control-C 13 | SubCondition:n/a
F76Cohort:INHA | Treatment:Matched control-C 14 | SubCondition:n/a
F77Cohort:INHA | Treatment:Matched control-C 15 | SubCondition:n/a
F78Cohort:INHA | Treatment:Matched control-C 16 | SubCondition:n/a
F79Cohort:INHA | Treatment:Matched control-C 17 | SubCondition:n/a
F80Cohort:INHA | Treatment:Matched control-C 18 | SubCondition:n/a
F81Cohort:INHA | Treatment:Matched control-C 19 | SubCondition:n/a
F82Cohort:INHA | Treatment:Matched control-C 1 | SubCondition:n/a
F83Cohort:INHA | Treatment:Matched control-C 20 | SubCondition:n/a
F84Cohort:INHA | Treatment:Matched control-C 21 | SubCondition:n/a
F85Cohort:INHA | Treatment:Matched control-C 2 | SubCondition:n/a
F86Cohort:INHA | Treatment:Matched control-C 3 | SubCondition:n/a
F87Cohort:INHA | Treatment:Matched control-C 4 | SubCondition:n/a
F88Cohort:INHA | Treatment:Matched control-C 5 | SubCondition:n/a
F89Cohort:INHA | Treatment:Matched control-C 6 | SubCondition:n/a
F90Cohort:INHA | Treatment:Matched control-C 7 | SubCondition:n/a
F91Cohort:INHA | Treatment:Matched control-C 8 | SubCondition:n/a
F92Cohort:INHA | Treatment:Matched control-C 9 | SubCondition:n/a
Data matrix
  logo